BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24883443)

  • 1. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
    Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
    Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.
    Wang Q; Zhu H; Xiao Z; Zhang W; Liu X; Zhang X; He J; Sun K; Wang L; Xu N
    World J Surg Oncol; 2013 Oct; 11():278. PubMed ID: 24131756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
    Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
    Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and predictive significance of SIRT1 and peroxisome proliferator-activated receptor gamma in esophageal squamous cell carcinoma: The correlation with EGFR and Survivin.
    Han F; Zhang S; Liang J; Qiu W
    Pathol Res Pract; 2018 May; 214(5):686-690. PubMed ID: 29625788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma.
    Li JC; Zhao YH; Wang XY; Yang Y; Pan DL; Qiu ZD; Su Y; Pan JJ
    Tumour Biol; 2014 Jan; 35(1):651-7. PubMed ID: 24052437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma.
    Cui X; Li S; Li T; Pang X; Zhang S; Jin J; Hu J; Liu C; Yang L; Peng H; Jiang J; Liang W; Suo J; Li F; Chen Y
    Int J Clin Exp Pathol; 2014; 7(5):2382-91. PubMed ID: 24966948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
    Wang H; Deng F; Liu Q; Ma Y
    Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
    Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of CD133 expression in esophageal squamous cell carcinoma.
    Okamoto H; Fujishima F; Nakamura Y; Zuguchi M; Ozawa Y; Takahashi Y; Miyata G; Kamei T; Nakano T; Taniyama Y; Teshima J; Watanabe M; Sato A; Ohuchi N; Sasano H
    World J Surg Oncol; 2013 Mar; 11():51. PubMed ID: 23448401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
    Inada S; Koto T; Futami K; Arima S; Iwashita A
    Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.